| Literature DB >> 31299336 |
Tao Jia1, Jéremy Ciccione2, Thibault Jacquet3, Manon Maurel4, Titouan Montheil4, Ahmad Mehdi5, Jean Martinez4, Béatrice Eymin1, Gilles Subra4, Jean-Luc Coll6.
Abstract
Covering the surface of a nanoparticle with polyethylene glycol (PEG) is a common way to prevent non-specific interactions but how its presence impacts on the activity of targeting ligands is still poorly documented. We synthesized a set of 9 silica nanoparticles grafted with c[RGDfK]-, a peptide targeting integrin αvß3 (cRGD), and/or with ATWLPPR, an anti-neuropilin 1 peptide (ATW). We then added various PEGs, and studied NPs binding on primary endothelial cells, the downstream activated signaling pathways and the impact on apoptosis. Our results show that the presence of PEG2000 on cRGD/ATW nanoparticles moderately improves cell binding but induces a 6000 times augmentation of AKT-dependent cell response due to the recruitment of other Receptor Tyrosine Kinases. Augmenting the length of the spacer that separates the peptides from the silica (using PEG3000) mainly resulted in a loss of specificity. Finally, the PEG-mediated hyperactivation of AKT did not protect endothelial cell from dying in the absence of serum, while its moderate activation obtained without PEG did. Finally, PEGylation of cRGD/ATW-NPs can generate nanoparticles with potent capacities to activate the AKT-GSK3β-eNOS cascade and to affect the resistance of endothelial cells to apoptosis. Thus, the impact of PEGylation should be precisely considered in order to avoid the apparition of counter-productive biological responses.Entities:
Keywords: AKT; Angiogenesis; Homomultimer and heteromultimer targeting; IGF-1R/IR; Neuropilin 1; α(v)ß(3) integrin
Year: 2019 PMID: 31299336 DOI: 10.1016/j.ijpharm.2019.118507
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875